Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

NCT02002702 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Heart Failure

Interventions

DRUG: Serelaxin
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals